This study gave the first estimates of HSV-2 per-sex-act FtoMTPs in Africa. It demonstrated a synergy between HIV and HSV-2 infections and a protective effect of male circumcision on HSV-2 acquisition by males.
To study the interactions between two sexually transmitted diseases without remission of the infections, we propose to use Markovian models. One model allows the estimation of the "per-partnership" female-to-male transmission probabilities for each infection, and the other the "per-sex-act" transmission probabilities. These models take into account the essential factors for the propagation of both infections, including the variability according to age of the rates of prevalence in the population of female partners for the male individuals constituting our sample. We estimate transmission probabilities and relative risks (for circumcision, usage of condoms and the effect of one infection on the infectivity of the other) by using the maximum likelihood method. Bootstrap procedures are used to provide confidence intervals for the parameters. We illustrate the new procedures with the study of the interactions between herpes simplex virus type 2 and human immunodeficiency virus by using data from the male circumcision trial that was conducted in Orange Farm (South Africa). The study shows that the probability that a susceptible male individual acquires one of the viruses is significantly higher when he is already infected with the other. Using the Akaike information criterion, we show that the per-partnership model fits the data better than the per-sex-act model. Copyright (c) 2010 Royal Statistical Society and University of Versailles-INSERM-APHP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.